Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

The following is a summary of "Comparison of prognostic scores according to WHO classification in 170 patients with advanced ...

Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic, describes the steps clinicians should take when they encounter clinical abnormalities that may point to systemic mastocytosis. (1:48 ...

Opens in a new tab or window An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase ...

After months of unanswered questions, Laura was finally told that her 17-month-old had mastocytosis - a rare condition caused by an excess number of mast cells gathering in the body's tissues.

A diagnosis of systemic mastocytosis should be considered in cases of unexplained splenomegaly. In Cureus, physicians presented the case of a patient with splenomegaly and sustained thrombocytopenia ...

Systemic mastocytosis (SM) is driven by KIT D816V mutation in approximately 95% of cases. 1 With the emergence of targeted treatments for indolent systemic mastocytosis (ISM) comes an opportunity to ...